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Introduction
Ghrelin is a peptide hormone, which has an effect on
growth hormone secretion and energy balance. It also has a
central effect on eating behavior and regulation of body 
weight. When first discovered, it has been considered as a
growth hormone secretagogue. In recent publications, 
attention has been drawn to its effects on appetite and 
weight regulation (1). More recently, ghrelin has been 
detected in cord blood (2). 
Ghrelin may be implicated in the stimulation of appetite
and growth hormone release in both rodents and humans
(3,4). Human subjects, who were given ghrelin by iv 
injection, reported increased ratings of hunger on a visual
analog scale (4).
Recent studies have reported the potential role of 
ghrelin in adaptation to intrauterine malnutrition (5). Lower
ghrelin levels have been related to slower growth in small
for gestational age (SGA) infants, and infants with lower
cord ghrelin levels have been reported to gain weight more 
slowly from birth to 2 years (6). 
The aim of this study was to investigate the relationship
between ghrelin and growth parameters at birth and at age
three months in healthy infants.
Methods
Newborn infants born in GATA Medical Faculty Hospital
between July 2005 and March 2006 by normal spontaneous
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was assessed by maternal last menstrual date and 
confirmed by Dubowitz scoring (7). We excluded infants
whose mothers had any clinical conditions such as diabetes
mellitus or, parathyroid disease, skeletal, renal and 
gastrointestinal dis-orders. None of the participating 
mothers smoked during pregnancy. Women who gave birth
to singleton term babies were recruited in the delivery 
room. A total of 60 babies (27 girls and 33 boys) were 
included in the study. The infants were divided into the 
following three groups using the Lubchenco intrauterine
growth curves (8):
Small for Gestational Age (SGA): This group included
20 babies with birth weights <10th percentile. 
Appropriate for Gestational Age (AGA): This group 
included 20 babies with birth weights between 10th and
90th percentiles.
Large for Gestational Age (LGA): This group included
20 babies with birth weights >90th percentile.
All newborns included in the study were healthy infants
and products of consecutive deliveries. Their mothers had
had no remarkable complications during pregnancy. None
of the infants had congenital malformations, chromosomal
abnormalities, or intrauterine infections. Their 5th minute
Apgar scores were ≥8 and their physical examinations 
were normal. Anthropometric measurements (length, 
weight, head circumference) were made on each infant and
blood samples were taken. 
Birth weight and birth length were obtained from each
neonate immediately after birth. The infants were weighted
naked on an electronic scale. For length measurements a
measuring board (head portion stable; feet portion mobile)
was used. Measurement of head circumference was done
on day 2 to allow for resolution of edema and head molding.
Head circumference measurements were made by passing
a non-stretch measuring tape from the glabella through the
occipital protuberance. Approval for the study was obtained
from the GATA Medical Faculty Ethics Committee on 
December 1, 2005 (48th session). Informed consent was
obtained from each mother before the blood samples were
taken from their infant. 
All infants were exclusively breast-fed throughout the
study. 
The blood samples (venous blood samples, 3-5 mL)
from each infant were taken in the early neonatal period
(first 7 days) and in the 3rd month, after a period of fasting
(approximately 90 minutes after feeding), between 9.00 am
and 9.30 am. All samples were assayed together at the end
of the study, so measurements of growth were recorded
blind to the hormone levels. The samples were collected in
ethylenediaminetetraacetic acid (EDTA) tubes. Within 
1 hour, the chilled samples were centrifuged, the plasma
was removed and stored at -70°C until being assayed.
Ghrelin levels were measured with Ghrelin Human EIA kit
(S-1222; Peninsula Laboratories Inc., Member of the 
Bachem Group, California, USA) by using ELISA 
(Enzyme-linked immunosorbent assay) method. A Micropla-
te Reader RT-2100 C device was used in the readings. 
Statistical Analysis
The data were expressed as means±SDs. The 
Kolmogorov-Smirnov test was applied separately for the
groups to check the normality of the variables. Differences
in the means of variables were tested using both parametric
and non-parametric tests depending on the distribution of
the variables between the groups. The changes in 
anthropometric measurements (length, weight and head
circumference) and serum ghrelin levels between baseline
values and values obtained at 3 months were separately
tested for the three groups using the paired-sample t-test.
Pearson’s correlations were used to examine relationships
among clinical growth-related parameters and hormone 
levels. Statistical significance was taken as p<0.05. All 
statistical analyses were performed using the Statistical
Package for Social Sciences (SPSS/Windows version 11.0,
SPSS inc., Chicago, IL, USA).
Results
Table 1 shows the findings of the infants at birth, at 3
months of age and the changes in these variables over 
time. There were no differences between males and 
females in terms of anthropometric data in any of the 
3 groups. There were also no significant gender differences
in ghrelin concentrations in the neonatal period or at 
3 months of age. 
While there were no significant differences between
their gestational ages, as expected, significant differences
existed between the groups at baseline in their 
anthropometric indices (Table 1). Ghrelin was significantly
higher in SGA and lower in LGA infants compared to AGA
infants, as depicted in Table 1 and also in Figure 1. 
At age 3 months, weight gain was significantly higher in
the AGA group babies than in the other groups (2837±631
grams in SGA, 3186±680 grams in AGA and 2726±637
grams in LGA group; p<0.001 between AGA and LGA 
groups). However, the percentage of weight gain was 
significantly higher in SGA babies than in LGA babies 
(124% vs. 64%). 
The change in ghrelin levels was significantly higher in
SGA (2.4±2.6 ng/dL) babies than in AGA (1.3±0.9 ng/dL)
and LGA (1.0±0.8 ng/dL) babies. The least change in 
ghrelin levels was in the LGA group. Ghrelin concentrations
were inversely correlated with change in weight (r=-0.577;
p=0.001), change in length (r=-0.361; p=0.005) and change
in head circumferences (r=-0.387; p=0.002) in the SGA 
group, but not in the other groups.
Ghrelin levels and changes are also depicted in Figure 1.
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Ghrelin has been proposed to be a hormone involved in
pre- and postnatal growth, and its serum levels have been
considered of prognostic value for postnatal catch-up
growth. In some studies ghrelin levels were reported to be
associated with anthropometric parameters (9,10). Also in
our study, ghrelin levels of SGA infants were found to be
higher when compared to AGA and LGA infants in the early
neonatal period and in the third month of life. These 
findings indicate that ghrelin takes part in the energy 
balance and is affected from intrauterine nutritional 
environment. In addition, we found that higher ghrelin 
levels are associated with more weight gain over the first
12 weeks of life in SGA infants. This finding implies that
SGA infants who are growing faster have a greater increase
in ghrelin levels from fasting values compared with AGA
and LGA infants growing at a slower pace.
High ghrelin concentrations sustained by a continuous
infusion have been associated with increased weight and
adiposity in mice (11). However, other researchers did not
report an effect of daily injections of ghrelin on weight gain
during the first postnatal week in neonatal rats, and the
ghrelin-null mouse model fails to support a role for ghrelin
in postnatal growth (12,13). The way ghrelin might 
influence weight gain in early infancy in humans is unclear,
but a simple explanation would be that lower ghrelin 
concentrations are associated with reduced appetite, 
resulting in lower nutritional intake. High circulating ghrelin
concentrations have been described in SGA neonates, and
SGA infants showing slower weight gain over the first year
of life had lower ghrelin levels after an iv glucose load
(3,14). These findings suggest that ghrelin may be an 
important regulator of weight gain in early infancy.
Ghrelin levels might be increased to induce appetite and
to form a positive energy balance after birth-at a time when
energy supply from the placenta ceases and breast-feeding
starts. Yokata et al (15) and Farquhar et al (5) found 
significantly higher ghrelin levels in term SGA infants 
compared to AGA and LGA infants in the postnatal period.
Higher ghrelin levels in the cord blood of SGA infants 
compared to AGA infants, and higher postnatal ghrelin 
concentrations compared to cord blood values in term 
newborns were reported (1,16). Savino et al (17) found a
positive correlation between the infant’s age and ghrelin
concentration. We have detected a positive correlation 
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Table 1. Anthropometric data and ghrelin levels at birth and after 3 months in the three groups
SGA AGA LGA
N2 0 2 0 2 0
Gestational age (weeks) 38±2.6 38±1.2 40±2.2
At birth
Weight (grams) 2285±227* 3273±231# 4215±247&
Length (cm) 47.7±2.3* 51.3±0.9# 53.4±1.3&
Head circumference (cm) 33.1±1.4* 34.5±0.4 34.6±0.63&
Ghrelin (ng/dL) 6.8±1.6* 3.4±1.9 2.7±1.6&
At 3 months
Weight (grams) 5122±770* 6460±758# 6941±745&
Length (cm) 56.5±2.74* 59.4±1.1# 63.2±2.3&
Head circumference (cm) 38.6±1.3* 40.6±0.7 40.7±0.7&
Ghrelin (ng/dL) 9.2±3.1* 4.8±2.7 3.8±2.3&
Changes in parameters
Weight gain (grams) 2837±631 3186±680# 2726±637
Weight gain (%) 124.1 97.3 64.6
Length gain (cm) 8.74±0.78* 8.11±0.67# 9.8±1.31&
Length gain (%) 18.4 15.7 18.3
Head circumference gain (cm) 5.5±0.38* 6.0±0.44 6.0±0.52&
Difference in Ghrelin level (ng/dL) 2.4±2.6 1.3±0.9 1.0±0.8&
SGA: small for gestational age, AGA: appropriate for gestational age, LGA: large for gestational age
*significance between SGA and AGA
#significance between AGA and LGA
&significance between SGA and LGAbetween ghrelin concentrations and weight gain in the 
postnatal period in term infants. Our findings are compatible
with the literature and suggest that ghrelin might play a 
role in growth in this period of life. 
There are reports which indicate that ghrelin levels may
be affected by acute changes as well as long-term changes
in energy balance. Plasma ghrelin levels vary as a 
consequence of the adaptive response to these 
circumstances. Bellone et al (18) demonstrated that, unlike
adults, ghrelin levels did not tend to decrease postprandially
in children, and concluded that the ghrelin system functions
somewhat differently in childhood. Savino et al (17) found
that in infants, ghrelin levels were lower in the 0-4 month
period. They did not observe any difference between 
breast-fed and formula-fed infants in the 4-8 month and 
8-12 month periods. In our study, all infants were 
breast-fed. As also reported by others (17,19), we found no
correlation between gender and ghrelin levels at birth and
at 3 months of age.
In conclusion, our findings indicate that in SGA babies,
higher ghrelin levels at birth are associated with faster 
weight gain in the first 3 months of life. 
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Figure 1. Ghrelin levels at birth, at 3 months and the differences in
ghrelin levels in the three groups
SGA: small for gestational age, AGA: appropriate for gestational age
LGA: large for gestational age 
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